11.71
+0.01(+0.09%)
Currency In USD
| Previous Close | 11.7 |
| Open | 11.6 |
| Day High | 11.98 |
| Day Low | 11.47 |
| 52-Week High | 16.93 |
| 52-Week Low | 8.64 |
| Volume | 1.19M |
| Average Volume | 2.22M |
| Market Cap | 1.9B |
| PE | -585.5 |
| EPS | -0.02 |
| Moving Average 50 Days | 12.01 |
| Moving Average 200 Days | 11.55 |
| Change | 0.01 |
If you invested $1000 in Certara, Inc. (CERT) since IPO date, it would be worth $307.51 as of July 01, 2025 at a share price of $11.71. Whereas If you bought $1000 worth of Certara, Inc. (CERT) shares 3 years ago, it would be worth $530.1 as of July 01, 2025 at a share price of $11.71.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Apr 29, 2025 8:15 PM GMT
RADNOR, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: BofA Securities 2025 H
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
GlobeNewswire Inc.
Apr 14, 2025 12:15 PM GMT
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety StudiesRADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization
GlobeNewswire Inc.
Apr 14, 2025 12:00 PM GMT
Reiterates Full-Year 2025 GuidanceArsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced expected reven